查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138354

全球人工耳蝸市場-2022-2029

Global Cochlear Implants Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

由於人口老齡化和技術進步等因素，人工耳蝸的全球市場正在增長，以提供更大的便利。

預計技術進步和人工耳蝸電池壽命的延長將推動市場增長。

不斷增長的老年人口（其中大約三分之一受到聽力損失的影響）是推動全球人工耳蝸市場增長的關鍵因素之一。例如，根據美國人口普查局的數據，全世界約有 8.5% 的人，即 6.17 億 65 歲以上的人患有聽力損失。根據世界衛生組織 (WHO) 2019 年報告，全球約有 4.66 億人患有致殘性聽力損失。據估計，到 2050 年，將有超過 9 億人患有聽力損失和殘疾。大約 11 億年輕人（12-35 歲）因在娛樂場所接觸噪音而面臨聽力損失的風險。

根據美國疾病控制與預防中心 (CDC) 的數據，到 2025 年，估計將有 9 億人患有嚴重的聽力損失。大約有 7200 萬人可以從使用人工耳蝸和助聽器等聽力設備中受益。因此，越來越多的聽力障礙者增加了對助聽器的需求。

此外，人工耳蝸的技術進步正在增強設備以提供更準確的信號並延長電池壽命。一些製造商正在努力提高人工耳蝸的質量和設計。 FDA 批准的 Nucleus 7 聲音處理器是第一款專為 iPhone、iPod 和 iPad 設計的人工耳蝸聲音解決方案。它的另一個特點是是目前市場上最小、最輕的耳後型人工耳蝸。

由於成本高且維護要求高，人工耳蝸預計會阻礙市場增長。

與手術相關的風險、人工耳蝸批准的等待期、人工耳蝸的高成本以及維修難度是阻礙市場增長的一些因素。

行業分析

全球人工耳蝸市場根據波特五力、監管分析、供應鏈分析、定價分析、產品創新和未滿足的需求等各種行業因素對市場進行了深入分析。

全球人工耳蝸市場報告提供對大約 45 多個市場數據表、40 多個數字和 180 頁的訪問。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 老年人聽力障礙增加
      • 人工耳蝸的技術進步和電池壽命的延長
    • 限制因素
      • 設備和維護成本高
      • 手術受傷的風險
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析
  • 產品創新
  • 未滿足的需求

第 6 章按類型

  • 單側植入
  • 雙側種植體

第 7 章，最終用戶

  • 兒科
  • 成人

第 8 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 9 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按類型進行基準測試
  • 值得關注的重點公司列表

第 10 章公司簡介

  • Cochlear Ltd.
    • 公司概況
    • 按類型和描述劃分的投資組合
    • 主要亮點
    • 財務摘要
  • MED-EL GmbH
  • Oticon Medical AB
  • Advanced Bionics AG
  • Demant A/S
  • Sonova Holding AG
  • Nurotron Biotechnology Co Ltd

第11章 人工耳蝸世界市場-DataM

簡介目錄
Product Code: DMMD2294

Market Overview

Cochlear Implants Market size was valued US$ 1.4 billion in 2021 and is estimated to reach US$ 2.5 billion by 2029, growing at a CAGR of 7.4% during the forecast period (2022-2029).

A cochlear implant is an electronic device that is surgically implanted that stimulates the cochlear nerve and restores the sense of hearing through transmitting the electrical signals to the brain. People mostly use these implants as a hearing aid with low to high hearing loss.

These cochlear implants consist of two parts, the inside component is embedded across the skin, and the external component is worn at the back of the ear. These implants bypass the non-functioning part of the inner ear and provide electrical stimulation to the nerve fibres present in the cochlea.

Market Dynamics

The global cochlear implant market is growing owing to several factors such as the rising geriatric population, technological advancements in devices to make them convenient for use.

Rising technological advancements and increased battery life of cochlear is expected to drive market growth.

The growing geriatric population, of which approximately one-third of people are affected by disabling hearing loss, is one of the major factors boosting the growth of the cochlear implants market globally. For instance, according to the U.S. Census Bureau, about 8.5% of people worldwide, i.e., 617 million were over age 65 were suffering from hearing loss. Also, according to the World Health Organization (WHO) report 2019, about 466 million people are having disabling hearing loss globally. It is estimated that over 900 million people will have disabling hearing loss by 2050. About 1.1 billion young people (age between 12-35 years) are at risk of hearing loss, owing to exposure to noise in recreational settings.

According to the Centres for Disease Control and Prevention (CDC), an estimated 900 million patients are likely to suffer from severe hearing impairment by 2025. There are approximately 72 million people who could potentially benefit from the use of a hearing device, including a cochlear implant or hearing aid. Hence, rising hearing disorders have increased the demand for hearing aid devices.

Also, the increasing technological advancements in cochlear implants are enhancing the devices to transfer signals more accurately and increase their battery life. Several manufacturers are involved in improving the quality and design of cochlear implants. The FDA-approved Nucleus 7 Sound Processor is the first cochlear implant sound solution made specifically for use with iPhones, iPods, and iPads. It also has the distinction of being the smallest and lightest behind-the-ear cochlear implant currently on the market.

High cost of the device and maintenance is expected to hamper the market growth.

Factors such the risk related to surgery, long awaiting approvals for cochlear implants, the high cost of cochlear implants and difficulty in maintenance are some of the factors hampering the growth of the market.

Industry Analysis

The global cochlear implants market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Product Innovation, Unmet Needs.

Segment Analysis

Bilateral implants segment is expected to hold the largest market share in global cochlear implants market

By type, the cochlear implants market is segmented into unilateral implants and bilateral implants. Among these, unilateral implants accounted for the largest market share, owing to their high demand globally. Unilateral implants are of lower cost compared to bilateral implants. According to some studies, the unilateral cochlear implant is more cost-effective for adults and has several health benefits.

On the other hand, the bilateral implants segment is estimated to grow at the fastest CAGR over the forecast period, owing to its ability to recognize the speech in noise, cost-effectiveness when implanted in children, and rising meningitis cases. Also, some countries offer reimbursement only after bilateral implantation, thus, increases the demand for these devices.

Geographical Analysis

North America region holds the largest market share in the global cochlear implants market

North America is dominating the global cochlear implant market accounted for the largest market share, owing to the developed healthcare system, better awareness among the people, and the presence of major market players in this region. The prevalence of hearing loss in the U.S. affects around 10.6 percent of the population, compared to 12.1 percent of the population in Germany and eight percent of those in Switzerland. According to Johns Hopkins Cochlear Center for Hearing and Public Health, approximately 38.2 million Americans (14.3%) report some degree of hearing loss.

According to the National Institute on Deafness and Other Communication Disorders, approximately one in three people in the United States between the ages of 65 and 74 have hearing loss, and nearly half of those older than 75 have difficulty hearing. The number of adults in the United States above 20 years of age with hearing loss is expected to increase from the expected 44.11 million in 2020 to 73.50 million in 2060. The increase is greater in older adults with an expected 55.4% of the US population above 70 years to suffer from hearing loss to 67.4% in 2060. The development of technologically advanced implants is boosting the growth of the market in this region. For instance, in April 2019, Advanced Bionics received approval from Health Canada for its HiRes Ultra 3D Cochlear Implant. The implant is a pain-free and hassle-free choice for patients undergoing MRI examinations.

Competitive Landscape

The global cochlear implants market is consolidated comprises only a few major players. Most of the major players are based in the US and Europe, as these regions are more developed and better funded for healthcare. Some of the major players in the market include Cochlear Ltd, MED-EL Medical Electronics, Oticon Medical, Advanced Bionics AG, Demant A/S, Sonova, Nurotron Biotechnology Co Ltd, among others.

The key players are adopting various growth strategies such as expansion, mergers & acquisitions, partnerships, product launches, and collaborations which are contributing to the growth of the Cochlear Implant market globally. For instance,

On July 22nd, 2019, MED-EL USA received the U.S. Food and Drug Administration (FDA) approval for its cochlear implant system for single-sided deafness (SSD) and asymmetric hearing loss (AHL). This is the first and only time that cochlear implants have been approved for these indications in the United States.

Key Companies to Watch

Cochlear Ltd.:

Overview: Cochlear is an Australia based medical device company which develops and markets variety of implants such as Nucleus cochlear implant, Baha bona conduction implants and hybrid electro-acoustic implants. It was founded in 1981, headquartered in Sydney, Australia.

Product Portfolio:

Nucleus 24 Cochlear Implant System: This is an implant that impart some hearing sensation to the user via electrical stimulation of auditory nerve. It contains 2 components, internal and external.

Key Developments: In 2019, Cochlear announced world's 1st active osseo-integrated steady state implant, Osia. It utilizes digital piezoelectric stimulation that bypass the damaged areas of hearing system by which sound vibrations directly reaches to cochlea.

The global cochlear implants market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

The companies such as Cochlear and Sensorion evaluates SENS-401 with a cochlear's implant. Cochlear invested about USD 1.8 million (€1.6 million) in shares of Sensorion as a part of this collaboration. In exchange, Cochlear would receive a right of first negotiation for a global license of SENS-401 in patients along with specific cochlear devices.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Growing hearing impairment in geriatric population
      • 4.1.1.2. Rising technological advancements and increased battery life of cochlear implants
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of the device and maintenance
      • 4.1.2.2. Risk of injuries in surgery
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Innovations
  • 5.6. Unmet Needs

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 6.1.2. Market Attractiveness Index, By Type Segment
  • 6.2. Unilateral Implantation
      • 6.2.1.1. Introduction
      • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Bilateral Implantation

7. By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 7.1.2. Market Attractiveness Index, By End User Segment
  • 7.2. Pediatrics
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Adults

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape

  • 9.1. Key Developments and Strategies
  • 9.2. Company Share Analysis
  • 9.3. Type Types Benchmarking
  • 9.4. List of Key Companies to Watch

10. Company Profiles

  • 10.1. Cochlear Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Type Type Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. MED-EL GmbH
  • 10.3. Oticon Medical AB
  • 10.4. Advanced Bionics AG
  • 10.5. Demant A/S
  • 10.6. Sonova Holding AG
  • 10.7. Nurotron Biotechnology Co Ltd

LIST NOT EXHAUSTIVE

11. Global Cochlear Implants Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and End User
  • 11.3. Contact Us